Clinical trial
Optimization of Golimumab Treatment in Ulcerative Colitis
NCT03669029 is registered in ClinicalTrials.gov with Hospital de Manises as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Golimumab Treatment in Ulcerative Colitis
- Lead sponsor
- Hospital de Manises
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- December 31, 2019
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.